BNP Paribas Asset Management
GMED icon

BNP Paribas Asset Management’s Globus Medical GMED Stock Holding History

BNP Paribas Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.2M Sell
1,027,808
-117,732
-10% -$10M 0.08% 230
2026
Q1 		$98.7M Buy
1,145,540
+39,934
+4% +$3.58M 0.11% 182
2025
Q4 		$103M Buy
1,105,606
+1,104,755
+129,818% +$83.9M 0.12% 166
2025
Q3 		$49K Sell
851
-244
-22% -$14.1K ﹤0.01% 1068
2025
Q2 		$65K Buy
+1,095
New +$70.7K ﹤0.01% 1057

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BNP Paribas Asset Management's GMED Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Globus Medical (GMED) stake by 10% in Q2 2026, selling an estimated $10M and leaving 1,027,808 shares worth $81.2M. The position accounts for 0.08% of the portfolio, ranked #230.

BNP Paribas Asset Management first reported a position in GMED in Q2 2025 and has held it in 5 quarters since. The position peaked at $103M in Q4 2025. 594 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • BNP Paribas Asset Management held 1,027,808 shares of Globus Medical worth $81.2M as of Q2 2026.
  • BNP Paribas Asset Management sold 117,732 Globus Medical shares in Q2 2026, an estimated $10M.
  • Globus Medical made up 0.08% of BNP Paribas Asset Management's portfolio in Q2 2026, its #230 holding.
  • BNP Paribas Asset Management first reported a position in Globus Medical in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Globus Medical position peaked at $103M in Q4 2025.
  • 594 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.